Education
About Us
Working with TipRanks
Follow Us
Tandem Diabetes Care (TNDM)
:TNDM
TNDM Analyst Ratings
Hold
6 Buy
12 Hold
2 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TNDM Stock 12 Month Forecast
Average Price Target
$20.33
▲(81.03% Upside)
| Highest Price Target$55.00 | Average Price Target$20.33 | Lowest Price Target$10.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
CFRA
$33→$22
Hold
95.90%
Upside
Reiterated
08/11/25
Lake Street
$12
Hold
6.86%
Upside
Initiated
08/11/25
Morgan Stanley
$17→$13
Hold
15.76%
Upside
Reiterated
08/11/25
Truist Financial
$17→$14
Hold
24.67%
Upside
Reiterated
08/07/25
Robert W. Baird
$24→$16
Hold
42.48%
Upside
Reiterated
08/07/25
Citi
$14→$10
Sell
-10.95%
Downside
Reiterated
08/07/25
Barclays
$53→$51
Buy
354.14%
Upside
Reiterated
08/07/25
Nephron
$14
Hold
24.67%
Upside
Downgraded
08/07/25
Mizuho Securities
$16
Hold
42.48%
Upside
Reiterated
08/07/25
Leerink Partners
$38→$32
Buy
184.95%
Upside
Reiterated
08/07/25
Canaccord Genuity
$59→$24
Buy
113.71%
Upside
Reiterated
08/07/25
UBS
$20→$17
Hold
51.38%
Upside
Reiterated
08/07/25
TD Cowen
$27→$20
Buy
78.09%
Upside
Reiterated
08/07/25
RBC Capital
$45→$25
Buy
122.62%
Upside
Reiterated
08/07/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
CFRA
$33→$22
Hold
95.90%
Upside
Reiterated
08/11/25
Lake Street
$12
Hold
6.86%
Upside
Initiated
08/11/25
Morgan Stanley
$17→$13
Hold
15.76%
Upside
Reiterated
08/11/25
Truist Financial
$17→$14
Hold
24.67%
Upside
Reiterated
08/07/25
Robert W. Baird
$24→$16
Hold
42.48%
Upside
Reiterated
08/07/25
Citi
$14→$10
Sell
-10.95%
Downside
Reiterated
08/07/25
Barclays
$53→$51
Buy
354.14%
Upside
Reiterated
08/07/25
Nephron
$14
Hold
24.67%
Upside
Downgraded
08/07/25
Mizuho Securities
$16
Hold
42.48%
Upside
Reiterated
08/07/25
Leerink Partners
$38→$32
Buy
184.95%
Upside
Reiterated
08/07/25
Canaccord Genuity
$59→$24
Buy
113.71%
Upside
Reiterated
08/07/25
UBS
$20→$17
Hold
51.38%
Upside
Reiterated
08/07/25
TD Cowen
$27→$20
Buy
78.09%
Upside
Reiterated
08/07/25
RBC Capital
$45→$25
Buy
122.62%
Upside
Reiterated
08/07/25
Best Analysts Covering Tandem Diabetes Care
1 Month
xxx
Success Rate
13/21 ratings generated profit
Average Return
+4.72%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 61.90% of your transactions generating a profit, with an average return of +4.72% per trade.
3 Months
xxx
Success Rate
9/21 ratings generated profit
Average Return
-0.52%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of -0.52% per trade.
1 Year
Success Rate
5/15 ratings generated profit
Average Return
-15.01%
reiterated a buy rating 5 days ago
Copying Matt Miksic's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -15.01% per trade.
2 Years
xxx
Success Rate
5/18 ratings generated profit
Average Return
-25.81%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 27.78% of your transactions generating a profit, with an average return of -25.81% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
TNDM Analyst Recommendation Trends
Rating
Apr 25
May 25
Jun 25
Jul 25
Aug 25
Strong Buy
20
17
12
9
8
Buy
2
1
1
1
1
Hold
11
14
15
18
22
Sell
1
0
0
1
2
Strong Sell
0
0
0
1
1
total
34
32
28
30
34
Each month's total comprises the sum of three months' worth of ratings.
TNDM Financial Forecast
TNDM Stock Forecast FAQ
What is TNDM’s average 12-month price target, according to analysts?
Based on analyst ratings, Tandem Diabetes Care’s 12-month average price target is 20.33.
What is TNDM’s upside potential, based on the analysts’ average price target?
Tandem Diabetes Care has 81.03% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is TNDM a Buy, Sell or Hold?
Tandem Diabetes Care has a consensus rating of Hold which is based on 6 buy ratings, 12 hold ratings and 2 sell ratings.
What is Tandem Diabetes Care’s price target?
The average price target for Tandem Diabetes Care is 20.33. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $55.00 ,the lowest forecast is $10.00. The average price target represents 81.03% Increase from the current price of $11.23.
The highest analyst price target is $55.00 ,the lowest forecast is $10.00. The average price target represents 81.03% Increase from the current price of $11.23.
What do analysts say about Tandem Diabetes Care?
Tandem Diabetes Care’s analyst rating consensus is a Hold. This is based on the ratings of 20 Wall Streets Analysts.
How can I buy shares of TNDM?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.